CM
IOVA icon

Caption Management’s Iovance Biotherapeutics IOVA Stock Holding History

Caption Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,500
Closed -$285K – 1786
2024
Q4 		$285K Buy
+38,500
New +$357K ﹤0.01% 1209
2024
Q3 		– Sell
-30
Closed -$241 – 1444
2024
Q2 		$241 Sell
30
-23,692
-100% -$254K ﹤0.01% 1113
2024
Q1 		$352K Buy
+23,722
New +$276K 0.01% 929
2023
Q4 		– Sell
-390,000
Closed -$2.04M – 1503
2023
Q3 		$1.77M Buy
390,000
+382,200
+4,900% +$2.5M 0.03% 614
2023
Q2 		$54.9K Hold
7,800
– – ﹤0.01% 1003
2023
Q1 		$47.7K Buy
+7,800
New +$53.8K ﹤0.01% 999
2022
Q4 		– Sell
-5,397
Closed -$52K – 1483
2022
Q3 		$52K Sell
5,397
-32,003
-86% -$369K ﹤0.01% 1382
2022
Q2 		$413K Buy
+37,400
New +$490K 0.01% 1108
2022
Q1 		– Sell
-70,625
Closed -$1.09M – 1693
2021
Q4 		$1.35M Buy
70,625
+41,118
+139% +$905K 0.02% 932
2021
Q3 		$728K Sell
29,507
-18,493
-39% -$436K 0.01% 1121
2021
Q2 		$1.25M Buy
+48,000
New +$1.25M 0.02% 829
2020
Q2 		– Sell
-145,200
Closed -$4.77M – 1067
2020
Q1 		$4.35M Buy
145,200
+143,600
+8,975% +$3.81M 0.25% 119
2019
Q4 		$44K Sell
1,600
-39,200
-96% -$892K ﹤0.01% 782
2019
Q3 		$743K Sell
40,800
-78,800
-66% -$1.74M 0.04% 432
2019
Q2 		$2.93M Buy
+119,600
New +$1.8M 0.15% 189

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Caption Management's IOVA Position: Q1 2025 in Review

Caption Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 38,500 shares — an estimated $285K sold.

Caption Management first reported a position in IOVA in Q2 2019 and held it in 15 quarters. The position peaked at $4.35M in Q1 2020. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

  • Caption Management reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Caption Management sold 38,500 Iovance Biotherapeutics shares in Q1 2025, an estimated $285K.
  • Caption Management first reported a position in Iovance Biotherapeutics in Q2 2019 and held it in 15 quarters.
  • Caption Management's Iovance Biotherapeutics position peaked at $4.35M in Q1 2020.
  • 302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.